The discovery of neomorphic mutations in KBTBD4 extends the spectrum of neomorphic mutations in cancer, highlighting KBTBD4 and the CoREST complex for further investigations of the origins and therapeutic opportunities in group 3/4 medulloblastomas. The gene discussed is KBTBD4; the disease is cancer.